
Loading, please wait...

Loading, please wait...

Degenerative Cervical Myelopathy symptoms often manifest as a subtle prodrome of pain long before significant neurological deficits appear. Chronic spinal cord compression causes this progressive condition, which clinicians often miss due to nonspecific early warning signs. Consequently, healthcare providers must understand the chronology of these symptoms to facilitate timely intervention and prevent irreversible damage.
The study analyzed 138 patients to identify the most frequent early indicators. Notably, neck pain and back pain emerged as the most common symptoms, occurring in 84.1% and 72.5% of participants, respectively. Furthermore, many patients recalled back pain (40.6%) and neck pain (31.9%) as the very first symptoms they experienced. These pain-related markers often persist for years before more recognizable signs, such as hand incoordination or gait imbalance, develop. Specifically, the mean duration for back pain reached approximately 8.6 years, whereas upper extremity (UE) pain lasted about 6.2 years. This long lead time suggests that chronic musculoskeletal pain in older adults warrants a high index of suspicion for underlying myelopathy.
Symptoms in DCM rarely occur in isolation. For instance, the co-occurrence of neck and back pain occurred in 65.2% of cases. Additionally, the combination of neck pain with UE numbness (57.2%) or gait imbalance (50.7%) is highly frequent. Although symptoms like saddle numbness and UE weakness are less common initially, patients often rate them as the most bothersome. Therefore, clinicians must look beyond isolated complaints and evaluate the patient for a constellation of sensory and motor changes. Prompt referral to a spine specialist remains the gold standard once these patterns are recognized.
The most common initial symptoms are neck and back pain, often occurring years before neurological deficits like hand clumsiness or walking difficulties.
Patients frequently report saddle numbness, upper extremity pain, and limb weakness as their most distressing symptoms, despite pain being the more frequent early sign.
Diagnosis is difficult because early symptoms like back pain and numbness are nonspecific and often attributed to general aging or other musculoskeletal conditions.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a substitute for professional healthcare. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Research reveals that neck and back pain often precede neurological deficits in Degenerative Cervical Myelopathy, offering critical clues for early diagnosi...
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today